Skip to main content

COVID-19 Advisory: If you have a fever or cold like symptoms, call us before visiting our clinics or emergency department. Only one primary caregiver may accompany a patient at all locations. No other visitors allowed. For more information visit our COVID-19 Resource Center.

Elizabeth M. Collyer, MD

Edit Profile
Elizabeth M. Collyer, MD

Specialty

Gastroenterology

Areas of Expertise

  • Celiac Disease

Office

Phoenix Children's Hospital - Main
1919 E. Thomas Rd., Phoenix, Arizona 85016
602-933-1000

Locations

Phoenix Children's Ambulatory & Specialty Center - NW Valley

20325 N 51st Ave
Glendale, AZ 85308-5665
United States

Get Driving Directions

Phoenix Children's Ambulatory & Specialty Center - Scottsdale

6990 E Shea Blvd
Scottsdale, AZ 85254-5200
United States

Get Driving Directions

Education & Training

Board Certification

General Pediatrics; Pediatric Gastroenterology

Medical School / Education

Pennsylvania State University College of Medicine, Hershey, PA

Residency

Penn State Hershey Children's Hospital, Department of Pediatrics

Fellowship

Cleveland Clinic Children's Hospital, Cleveland, OH (Pediatric Gastroenterology, Hepatology, and Nutrition)

Internship

Penn State Hershey Children's Hospital, Department of Pediatrics

Academic Affiliations

Assistant Professor of Pediatrics, Mayo Clinic College of Medicine and Science; Assistant Clinical Professor of Pediatrics, Creighton University School of Medicine-Phoenix, AZ; Clinical Assistant Professor of Child Health, University of Arizona College of Medicine- Phoenix, AZ

Professional Affiliations

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN); Maricopa County Medical Society

Research & Publications

Peer Reviewed

Collyer E and Kaplan B. Non-celiac gluten sensitivity: An Approach to Diagnosis and Management" Current Opinion in Pediatrics 2016 Oct;28(5):638-43.

Mansoor S, Collyer E, and Alkhouri N. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease." Current Gastroenterology Reports. 2015 Jun;17(6):23.

Publications

Collyer E, Eghtesad, B, Hupertz V, and Radhakrishnan K. Liver Transplantation as a Treatment for Severe Refractory Vitamin E Deficiency Related to Progressive Familial Intrahepatic Cholestasis Type 2 in a Pediatric Patient" ACG Case Reports Journal. Volume 3 Issue 4, page 1-2 12/21/16.

Collyer E, Patel S, Anani A, Lappe S, Grove D, Dweik R, Alkhouri N. Analysis of Volatile Organic Compounds in the Exhaled Breath of Patients with Celiac Disease." Pediatrics. Feb 2016 137 (Supplement 3) 191A.

Collyer E, Alkhouri N, Mansoor S, Lappe S, Lopez R, and Nobili V. Plasma Cytokeratin 18 (CK18) Level as a Novel Biomarker for Predicting the Presence of Liver Fibrosis in Children with Nonalcoholic Fatty Liver Disease (NAFLD)" Pediatrics. Feb 2016 137 (Supplement 3) 190A

Mandelia C, Collyer E, Mansoor S, Lopez R, Lappe S, Nobili V, Alkhouri N. Plasma Cytokeratin-18 Level as a Novel Biomarker for Liver Fibrosis in Children with Nonalcoholic Fatty Liver Disease." JPGN. 2016 Jan 29. [Epub ahead of print] and in hard copy JPGN 2016 Aug;63(2):181-7.

Collyer E, Patel S, Anani A, Lappe S, Grove D, Dweik R, Alkhouri N. Analysis of Volatile Organic Compounds in the Exhaled Breath of Patients with Celiac Disease." JPGN. 61, S2:115 September 2015.

Collyer E, Alkhouri N, Mansoor S, Lappe S, Lopez R, and Nobili V. Plasma Cytokeratin 18 (CK18) Level as a Novel Biomarker for Predicting the Presence of Liver Fibrosis in Children with Nonalcoholic Fatty Liver Disease (NAFLD)" JPGN. 61, S2:60. September 2015.

Alkhouri N, Anton E, Gali K, Lappe S, Collyer E, Mahajan A. Feasibility of acoustic radiation force impulse (ARFI) in children with nonalcoholic fatty liver disease (NAFLD)." JPGN. 61, S2: 123-124. September 2015.

Collyer E, Kay M. Fluoxetine-induced transaminitis in an adolescent patient." American Journal of Gastroenterology 109: S593-S597. October 2014.

Collyer E and Kay M. Response to Fontana et al. - Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and Those with Cholestatic Drug Induced Liver Injury" American Journal of Gastroenterology. 111 (2):297. February 2016.

In Progress

Collyer E, Patel S, Anani A, Lappe S, Grove D, Dweik R, Alkhouri N. Analysis of Volatile Organic Compounds in the Exhaled Breath of Patients with Celiac Disease."

Collyer E, Matloob A, Macknin M, , Lappe S, Grove D, Cikach F, Okwu V, Worley S, Dweik R, Alkhouri N. Effects of dietary intervention on breath volatile organic compounds in obese children with hypercholesterolemia."

Share this page